Caprock Cardiac Center Research Institute
Lubbock, Texas 79410
0 studies enrolling now · 2 studies all time
What they study most
Acute Coronary Syndromes, Atrial Fibrillation, Stroke
Studies at this site
- GLORIA-AF Registry Program - Second and Third Phases — Completed
- A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart — Completed